Beta-blocker treatment for chronic heart failure. The frog prince.
- 1 October 1994
- journal article
- abstracts
- Published by Wolters Kluwer Health in Circulation
- Vol. 90 (4) , 2153-2156
- https://doi.org/10.1161/01.cir.90.4.2153
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Long-term (3-month) effects of a new beta-blocker (nebivolol) on cardiac performance in dilated cardiomyopathyJournal of the American College of Cardiology, 1993
- Pathophysiologic and pharmacologic rationales for clinical management of chronic heart failure with beta-blocking agentsThe American Journal of Cardiology, 1993
- Usefulness of bucindolol in congestive heart failureThe American Journal of Cardiology, 1990
- Improvement in exercise performance and hemodynamics by labetalol in patients with idiopathic dilated cardiomyopathyAmerican Heart Journal, 1990
- Beta blockade during and after myocardial infarction: An overview of the randomized trialsProgress in Cardiovascular Diseases, 1985
- A randomized trial of low-dose beta-blockade therapy for idiopathic dilated cardiomyopathyThe American Journal of Cardiology, 1985
- Timolol-Induced Reduction in Mortality and Reinfarction in Patients Surviving Acute Myocardial InfarctionNew England Journal of Medicine, 1981
- Adverse effects of beta-blockade withdrawal in patients with congestive cardiomyopathy.Heart, 1980
- Beneficial effects of long-term beta-blockade in congestive cardiomyopathy.Heart, 1980
- Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy.Heart, 1975